TALOS is a medical AI company developing ANRISK, a risk assessment solution for intracranial aneurysm. The software uses routine health checkup data to estimate an individual’s brain aneurysm risk without requiring imaging as the first step. Rather than replacing MRA or clinical diagnosis, ANRISK is designed to help screening institutions identify higher-risk groups earlier and use medical resources more efficiently. The company focuses on preventive medicine, cerebrovascular disease prediction and data-based health screening.